Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
The OncLive Insider app is live!
CME Opportunities
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Expanding the Armamentarium in Metastatic Liver Cancer
EP. 1: Trends and Risk Factors in Liver Cancer
February 23rd 2018
EP. 2: HCC: Multidisciplinary Decision-Making
February 23rd 2018
EP. 3: Response and Outcomes With TKIs in HCC
February 23rd 2018
EP. 4: Second-Line Nivolumab in Liver Cancer
February 23rd 2018
EP. 5: HCC: Considerations in Toxicity Management
February 23rd 2018
EP. 6: Proactive Management of TKI Side Effects in HCC
February 23rd 2018
EP. 7: HCC: Nivolumab's Side Effects
February 23rd 2018
EP. 8: Sequencing Considerations in HCC
February 23rd 2018
EP. 9: Frontline Clinical Trials in Liver Cancer
February 23rd 2018
EP. 10: Emerging Second-Line Therapies in HCC
February 23rd 2018
EP. 11: Novel Combinations on the Horizon in HCC
February 23rd 2018
EP. 12: Growing Treatment Landscape in Liver Cancer
February 23rd 2018
EP. 13: Managing Locoregional Therapies in HCC
February 23rd 2018
EP. 14: Locoregional Therapies for Extrahepatic HCC
February 23rd 2018
EP. 15: Interventional Radiology and More for HCC
February 23rd 2018
x